GlassScriptPhysician profile
Gemma Lim Go
NPI 1538585005
$1,844.34
in general payments reported to CMS, 2019-2025
21 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $190 · 2022: $484 · 2023: $691 · 2024: $222 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,170.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $249.94 | 2023 | Afrezza |
| Astrazeneca Pharmaceuticals LP | $194.95 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $151.52 | 2022 | |
| Daiichi Sankyo INC. | $135.42 | 2025 | Injectafer |
| Horizon Therapeutics Plc | $124.97 | 2023 | Krystexxa |
| Amylyx Pharmaceuticals, INC. | $122.45 | 2023 | Relyvrio |
| Idorsia Pharmaceuticals US INC | $121.95 | 2023 | Quviviq |
| Gilead Sciences, INC. | $121.78 | 2025 | Vemlidy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.58 | 2022 | |
| Argenx US, INC. | $120.06 | 2024 | Vyvgart Hytrulo |
| Ultragenyx Pharmaceutical INC. | $102.36 | 2024 | Dojolvi |
| Biogen, INC. | $92.25 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $32.51 | 2022 | |
| Lilly USA, LLC | $27.61 | 2022-2023 | Mounjaro |
| Abbott Laboratories | $22.06 | 2023 | Freestyle Libre 2 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $19.80 | 2023 | Tresiba, Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $19.76 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $19.49 | 2021 | |
| Exact Sciences Corporation | $15.62 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $15.42 | 2022 | |
| Glaxosmithkline, LLC. | $12.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gemma Lim Go listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.